Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Retatrutide Dosage: A Guide to the Research Key Takeaways Retatrutide is an investigational weekly injection being studied for weight loss
Protect it from excessive heat and sunlight, and keep the cap on when not in use
Tirzepatide's dual GLP-1 and GIP receptor activation creates a more potent appetite suppression and metabolic benefit profile than semaglutide monotherapy
Study Outcomes and Follow-Up The primary outcome of interest was the incidence of PsA, identified by ICD-10-CM code L40.5
To be market-worthy, the drug needed to remain active 24 hours a day, remain physically stable for long periods of time and be as or more potent than native GLP-1
